Jianfeng Group Lin2016 -017 (Announcement of Resolutions of the 7th Session of the 9th Board of Directors)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 No.: Pro 2015-017
Bond Abbreviations: 13 Peak 01 Bond Code: 122227
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement of the Seventh Session of the Ninth Board of Directors
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2016# On April 14, 36, the company issued the notice of the board meeting by fax, e-mail and personal service.
(III) 2016# On April 28, 40, the board meeting was held by means of communication voting.
The (IV) company currently has eight directors and 8directors who voted.
2. Board Meeting Review1
, 2016 First Quarter Report
The Board of Directors reviewed and approved the report.Voting result: 8
votes in favor, 0 votes against, 0 abstentions. The first quarter report of
2016can be found on the website of Shanghai Stock Exchange (www.sse.com.cn ).
2, Proposal on Adding Members of the Audit Committee of the Board of Directors
The board of directors reviewed and passed the proposal, and agreed to add Mr. Jiang Xiaomeng as a member of the audit committee of the ninth board of directors of the company. The term of office is consistent with the current board of directors. (resume attached)voting result: 8
votes in favor, 0 votes against and 0 abstentions.
is hereby announced.Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 30, 2016
Resume:
Mr. Jiang Xiaomeng, born in November 1964
, master of business administration/master of engineering, professor-level senior engineer, licensed pharmacist, experts enjoying the special allowance of the State Council, young and middle-aged experts with outstanding contributions in Zhejiang Province, participated in the work in December 1980, successively served as the workshop director of Jinhua Cement Plant, the manager of the company's enterprise management department, the general manager of Zhejiang Jianfeng Communication Cable Co., Ltd., and Zhejiang Jianfeng General Manager of Pharmaceutical Co., Ltd., deputy general manager and general manager of the company. He is currently the Chairman and Secretary of the Party Committee of the Company, concurrently serving: vice Chairman of the Board of Directors of Tianshili Holding Group Co., Ltd., Vice Chairman of Tianshili Pharmaceutical Group Co., Ltd., Director of Southern Cement Co., Ltd., Chairman of Zhejiang Jinhua Nanfang Jianfeng Cement Co., Ltd., Director of Jinhua Tongji State-owned Assets Investment Co., Ltd., Zhejiang Vice President of Entrepreneurs Association, Vice President of Zhejiang Productivity Society, Vice President of Zhejiang Pharmaceutical Industry Association, Vice President of Zhejiang Building Materials Industry Association, Jinhua Entrepreneurs Association.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page